Tianjin Pharmaceutical Group International Holdings
VC Fund
Tianjin, China
Tianjin Pharmaceutical Group International Holdings is a VC fund in Tianjin focused on Video and Consumer. Tianjin Pharmaceutical Group International Holdings a large pharmaceutical enterprise in China. They specializes in the research, development, production, and sale of pharmaceutical products.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Tianjin Pharmaceutical Group International Holdings invests in
Stages Tianjin Pharmaceutical Group International Holdings invests in
Countries Tianjin Pharmaceutical Group International Holdings invests in
Investment Focus
Industry
- Video 1 (33%)
- Consumer 1 (33%)
- Health Care 1 (33%)
- Neuroscience 1 (33%)
- Therapeutics 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Post-IPO Equity 1 (33%)
Country
- China 2 (67%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Huiyong Pharmaceutical
|
Huiyong Pharmaceutical is a platform-based R&D company that focuses on key technologies for high-end preparations and unmet clinical needs. | $30.9M / Series A / Mar 01, 2021 | |
| Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research hasallowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases. | $20M / Post-IPO Equity / Dec 12, 2016 | ||
| Baofeng Mojing Chinese video streaming company. Baofeng Mojing appears to be a few steps ahead of the market in that its product is already available to consumers. It’s also one of the cheapest VR experiences on the market, | $35M / Series B / Jan 22, 2016 |
Co-Investors
Aisidi
1 deal together
Baofeng Xinying
1 deal together
CITIC Capital Holdings
1 deal together
Huayi Brothers Media Group
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Tianjin Pharmaceutical Group International Holdings invest in?
Tianjin Pharmaceutical Group International Holdings invests primarily in Video, Consumer and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Tianjin Pharmaceutical Group International Holdings last invest?
The most recent investment recorded for Tianjin Pharmaceutical Group International Holdings closed in Mar 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
